Bing vs. Bard, US-China STEM Competition, and Embryo Screening — #30

Release Date:


Steve discusses the competition between Microsoft and Google, the competition between the U.S. and China in STEM, China’s new IVF policy, and a Science Magazine survey on polygenic screening of embryos.00:00 Introduction02:37 Bing vs Bard: LLMs and hallucination20:52 China demographics & STEM34:29 China IVF40:28 Survey on embryo screening in ScienceReferences:Bing vs Bard and Hallucination https://twitter.com/hsu_steve/status/1625222378383876119China demographics and STEMhttps://twitter.com/hsu_steve/status/1620765589752119297https://twitter.com/hsu_steve/status/1623279827640848385China IVFhttps://twitter.com/hsu_steve/status/1623475304432820224https://twitter.com/hsu_steve/status/1623478413758500864Survey on embryo screeninghttps://twitter.com/hsu_steve/status/1623783244947722241https://twitter.com/hsu_steve/status/1623664372202500097Music used with permission from Blade Runner Blues Livestream improvisation by State Azure.--Steve Hsu is Professor of Theoretical Physics and of Computational Mathematics, Science, and Engineering at Michigan State University. Previously, he was Senior Vice President for Research and Innovation at MSU and Director of the Institute of Theoretical Science at the University of Oregon. Hsu is a startup founder (Superfocus.ai, SafeWeb, Genomic Prediction, Othram) and advisor to venture capital and other investment firms. He was educated at Caltech and Berkeley, was a Harvard Junior Fellow, and has held faculty positions at Yale, the University of Oregon, and MSU.Please send any questions or suggestions to manifold1podcast@gmail.com or Steve on Twitter @hsu_steve.

Bing vs. Bard, US-China STEM Competition, and Embryo Screening — #30

Title
Bing vs. Bard, US-China STEM Competition, and Embryo Screening — #30
Copyright
Release Date

flashback